Tideglusib is a small-molecule drug of the thiadiazolidinone class that functions as an irreversible, non-ATP-competitive inhibitor of glycogen synthase kinase 3 (GSK-3β), currently under investigation… Read more
Tideglusib is a small-molecule drug of the thiadiazolidinone class that functions as an irreversible, non-ATP-competitive inhibitor of glycogen synthase kinase 3 (GSK-3β), currently under investigation for its potential role in treating neurodegenerative conditions such as Alzheimer’s disease and progressive supranuclear palsy. To support the rigorous demands of pharmaceutical development, laboratories utilize high-quality reference standards, non-pharmacopeial impurities, and stable isotope labelled compounds to ensure analytical precision. These specialized materials are essential for accurate impurity profiling and method validation throughout the drug's development lifecycle. Stable isotope labelled analogues, in particular, serve as reliable internal standards in bioanalytical studies, providing the necessary accuracy for quantification within complex biological matrices. By employing these precise reference materials, researchers maintain data integrity and consistency during quality control procedures, ensuring that preclinical and clinical testing meet stringent regulatory expectations for chemical identification and safety assessments.